Loading data for RDY — first visit, this takes a few seconds.
Dr. Reddy's Laboratories ... (RDY)
NYSE: RDY
· Real-Time Price · USD
12.18
+0.07 (0.58%)
At close: Aug 21, 2026, 8:00 PM
12.18
+0.00%
After-hours: 7:47 PM
The price, the headline numbers and the latest news, in one place.
Dr. Reddy's Laboratories Limited (RDY) Stock Price, Analysis & Data
0.58% (1D)
No data available
| Bid | 12 |
| Market Cap | 10.15B |
| Revenue (ttm) | 331.19B |
| Net Income (ttm) | 33.11B |
| 0.24 | |
| 0.42 | |
| 29 | |
| 18.79 | |
| P/B (ttm) | 15.13 |
| P/S (ttm) | 0.03 |
| Earnings Date | Oct 22, 2026 |
| Ask | 12.18 |
| Volume | 1,746,775 |
| Avg. Volume (20D) | 2,591,133 |
| Open | 12.13 |
| Previous Close | 12.11 |
| Day's Range | 12.06 - 12.22 |
| 52-Week Range | 11.36 - 15.67 |
| Analyst | n/a |
| Price Target | n/a |
| Dividends | $0.08 (0.69%) |
| Ex-Dividend Date | Jul 9, 2026 |
About RDY
Dr. Reddy's Laboratories Limited, together with its subsidiaries, operates as an integrated pharmaceutical company North America, Europe, India, Russia, and internationally. The company operates through Global Generics, Pharmaceutical Services and Active Ingredients (PSAI), and Others segment. Its Global Generics segment manufactures and markets prescription and over-the-counter finished pharmaceutical products that are marketed under a brand nam...
Sector Healthcare
IPO Date Apr 11, 2001
Employees 27,527
Stock Exchange NYSE
Ticker Symbol RDY
Website https://www.drreddys.com
Financial Performance
In 2026, Dr. Reddy's Laboratories's revenue was 335.93B, an increase of 3.19% compared to the previous year's 325.54B. Earnings were 42.85B, a decrease of -24.22%.
Financial StatementsEarnings Surprise
Dr. Reddy's Laboratories has released their quarterly earnings on May 9, 2025:
- Revenue of $80.7B misses estimates by $0, with -5.56% YoY decline.
- EPS of 19.11 exceeds estimates by 1.98, with 22.97% YoY growth.
Dr. Reddy's Laboratories Limited is scheduled to release its earnings on Oct 22, 2026, before market opens.
Analysts project revenue of ... Upgrade
Analysts project revenue of ... Upgrade
Page 1 of 2